Based in Dallas, Texas, AveXis is a clinic-stage gene therapy platform company establishing unique industry alliances to create innovative treatments for people with unmet medical needs. Spinal muscular atrophy (SMA) is the company's first focus.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/12/15 | $10,000,000 |
Deerfield Management Company, L.P. Roche Venture Fund | undisclosed | |
| 09/09/15 | $65,000,000 | Series D |
Adage Capital Management Deerfield Management Company, L.P. Foresite Capital Janus Capital QVT Financial RA Capital Roche Venture Fund Rock Springs Capital RTW Investments T. Rowe Price Associates Venrock | undisclosed |
